Bloomberg -- Johnson & Johnson recalled batches of its Simponi arthritis treatment in Germany and withheld shipments that will cause shortages in Europe, adding to glitches that cost the company more than $900 million last year.
Bloomberg -- Johnson & Johnson recalled batches of its Simponi arthritis treatment in Germany and withheld shipments that will cause shortages in Europe, adding to glitches that cost the company more than $900 million last year.
